[Local data] A local review on childhood lead poisoning

3 min read /
Other General Medicine Paediatrics Public health
[Local data] A local review on childhood lead poisoning

A local review paper on childhood lead exposure and poisoning, as well as medical management strategies.

Background:

  • Childhood lead poisoning is a key public health concern among different countries
  • In 2015, a major health crisis happened in Hong Kong, where a number of public housing estates were found to have lead present in the drinking water

 

Possible sources of childhood lead exposure and poisoning:

  • Natural source including air, dust, soil and water
  • Industrial source including smelters, refineries, mines, lead gasoline, etc.
  • Household water from copper plumbing with lead solder
  • Human breast milk
     

Clinical manifestations or complications of lead poisoning:

  • Lead poisoning in the majority of children is asymptomatic
  • Neurological manifestations: acute encephalopathy, hearing loss, neurobehavioral disorder such as hyperactivity, developmental delay, etc.
  • Physiological complications: colicky abdominal pain, constipation, growth retardation, anemia, etc.
     

Screening for lead poisoning in children:

  • The American Academy of Neurology: Children with developmental delay, including those with known identifiable risk factors for excessive lead exposure are suggested to be screened for lead toxicity
  • Hong Kong government: Children aged under 12 years with a borderline raised blood lead level (5 mcg/dL*) should be conducted with lead exposure risk assessment and developmental assessment, while all citizens should be continuously monitored with raised blood lead levels
    *correlates with the targeted screening promoted by the Advisory Committee on Childhood Lead Poisoning Prevention (ACCLPP)
     

Medical management strategies for childhood lead poisoning:

  • Performing evaluation and/or intervention based on the blood lead levels:
  • Below 20 mcg/dL:
  • For asymptomatic children: provide long-term neurodevelopmental follow-up and counselling, while conduct periodic blood sampling to stabilize lead level until lower than 5 mcg/dL
  • For symptomatic patients: measure blood lead level and review the child’s clinical status at least every 3 months, while treat iron deficiency promptly, and refer for environmental investigation and management
  • Between 20 and 45 mcg/dL: lower the exposure to all sources of lead, correct any iron deficiency, maintain an adequate calcium intake, and frequently monitor to ensure the child’s blood lead levels are decreasing
  • At or above 45 mcg/dL: Conduct chelation therapy after repeated blood lead measurement for confirmation, or immediately if encephalopathy is suspected
     

Monitoring the neurodevelopmental outcomes:

  • Provide nutritional support, e.g. sufficient intake of calcium, vitamins C and D to minimize lead absorption
  • Conduct preventive measures and education on lead exposure
  • Follow up continuously with children at least after the environmental sources of lead have been identified and eliminated, with blood lead level declined to below 15 mcg/dL for not less than 6 months
  • Monitor long-term neurodevelopment even a case is closed, until the child reached 6 years old

Link to full article: http://www.hkmj.org/abstracts/v23n6/616.htm

 

Reference

Hon KL, Fung CK, Leung AK. Childhood lead poisoning: an overview. Hong Kong Med J. 2017;23(6):616-21.

WYE-EM-010-JAN-18